FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jaume Mora

Research Profile

Disorders

Concepts & Ideas

Physiology

Living Beings

Infants

Procedures

Anatomy

Schwann Cells

Chemicals & Drugs

Devices

Oligonucleotide Array Sequence Analysis

Co-author Network

Publications

TOP 3
Carla Casalà; Enrique de Alava; Patricia Galván; Estel Gil-Guiñón; Cinzia Lavarino; Solange Miguel-Queralt; Jaume Mora; Francina Munell; José Luis Ordóñez; Eva Rodríguez; Carmen de Torres
The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.
Laia Masvidal; Jaume Mora; Eva Rodríguez; Carla Casalà; Patricia Galván; Raquel Iniesta; Cinzia Lavarino; Carmen de Torres
Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.
Idoia Garcia; Barbara Hero; Garrett M Brodeur; Nai-Kong V Cheung; Carmen de Torres; Gema Domenech; Matthias Fischer; Patricia Galvan; John M Maris; Gemma Mayol; Jaume Mora; André Oberthuer; José Ríos; Eva Rodríguez; Mariona Suñol; Cinzia Lavarino
A three-gene expression signature model for risk stratification of patients with neuroblastoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jaume Mora (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Carla Casalà; Enrique de Alava; Patricia Galván; Estel Gil-Guiñón; Cinzia Lavarino; Solange Miguel-Queralt; Jaume Mora; Francina Munell; José Luis Ordóñez; Eva Rodríguez; Carmen de Torres
The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.
Carcinogenesis 2013;34(2):268-76.
2013: Laia Masvidal; Jaume Mora; Eva Rodríguez; Carla Casalà; Patricia Galván; Raquel Iniesta; Cinzia Lavarino; Carmen de Torres
Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.
PloS one 2013;8(3):e59762.
2012: Idoia Garcia; Barbara Hero; Garrett M Brodeur; Nai-Kong V Cheung; Carmen de Torres; Gema Domenech; Matthias Fischer; Patricia Galvan; John M Maris; Gemma Mayol; Jaume Mora; André Oberthuer; José Ríos; Eva Rodríguez; Mariona Suñol; Cinzia Lavarino
A three-gene expression signature model for risk stratification of patients with neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(7):2012-23.
2012: Gemma Mayol; Jaume Mora; Ana Queiros; José Ríos; Eva Rodríguez; Mariona Suñol; Carmen de Torres; Manel Esteller; Patricia Galván; Idoia Garcia; Soledad Gómez; Marta Kulis; José I Martín-Subero; Cinzia Lavarino
DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis.
PloS one 2012;7(11):e48401.
2011: Sandra Acosta; Katleen De Preter; Carmen de Torres; Idoia Garcia; Candy Kumps; Cinzia Lavarino; Gemma Mayol; Eva Rodríguez; Jaume Mora
Identification of tumoral glial precursor cells in neuroblastoma.
Cancer letters 2011;312(1):73-81.
2010: Idoia Garcia; Gemma Mayol; Eva Rodríguez; Mariona Suñol; Timothy Gershon; José Ríos; Nai-Kong V Cheung; Mark W Kieran; Rani E George; Antonio R Perez-Atayde; Carla Casala; Patricia Galván; Carmen de Torres; Jaume Mora; Cinzia Lavarino
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
Molecular cancer 2010;9():277.
2009: Carmen de Torres; Helena Beleta; Rubén Díaz; Núria Toran; Eva Rodríguez; Cinzia Lavarino; Idoia García; Sandra Acosta; Mariona Suñol; Jaume Mora
The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
Cancer 2009;115(12):2792-803.
2007: Jaume Mora; Cinzia Lavarino; Miguel Alaminos; Nai-Kong V Cheung; José Ríos; Carmen de Torres; PETER ILLEI; Gloria Juan; William L Gerald
Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma.
Genes, chromosomes & cancer 2007;46(4):385-96.
2005: Miguel Alaminos; Verónica Dávalos; Santiago Ropero; Fernando Setién; Maria Fe Paz; Michel Herranz; Mario F Fraga; Jaume Mora; Nai-Kong V Cheung; William L Gerald; Manel Esteller
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
Cancer research 2005;65(7):2565-71.
2004: Wendy T Su; Miguel Alaminos; Jaume Mora; Nai-Kong V Cheung; Michael P LaQuaglia; William L Gerald
Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas.
Cancer genetics and cytogenetics 2004;154(2):131-7.
2004: Jaume Mora; Miguel Alaminos; C de Torres; PETER ILLEI; Jing Qin; Nai-Kong V Cheung; William L Gerald
Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours.
British journal of cancer 2004;91(6):1112-8.
2003: Jaume Mora; Daniel A Filippa; Jing Qin; Norma Wollner
Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Cancer 2003;98(6):1283-91.
2003: Miguel Alaminos; Jaume Mora; Nai-Kong V Cheung; Alex Smith; Jing Qin; Lishi Chen; William L Gerald
Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma.
Cancer research 2003;63(15):4538-46.
2002: Jaume Mora; William L Gerald; Jing Qin; Nai-Kong V Cheung
Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma.
Cancer 2002;94(10):2756-65.
2002: Jaume Mora; Nai-Kong V Cheung; Sandra Oplanich; Lishi Chen; William L Gerald
Novel regions of allelic imbalance identified by genome-wide analysis of neuroblastoma.
Cancer research 2002;62(6):1761-7.
2002: Jaume Mora; MUZAFFAR M AKRAM; William L Gerald
Comparison of normal and tumor cells by laser capture microdissection.
Methods in enzymology 2002;356():240-7.
2001: Jaume Mora; Nai-Kong V Cheung; Gloria Juan; PETER ILLEI; Irene Y Cheung; MUZAFFAR M AKRAM; S Chi; Marc Ladanyi; Carlos Cordon-Cardo; William L Gerald
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell.
Cancer research 2001;61(18):6892-8.
2001: Jaume Mora; Nai-Kong V Cheung; William L Gerald
Genetic heterogeneity and clonal evolution in neuroblastoma.
British journal of cancer 2001;85(2):182-9.
2001: Jaume Mora; Nai-Kong V Cheung; Lieping Chen; Jing Qin; William Gerald
Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1358-61.
2001: Jaume Mora; Nai-Kong V Cheung; Lieping Chen; Jing Qin; William Gerald
Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease.
Cancer 2001;91(2):435-42.
2001: Nai-Kong V Cheung; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; SV Gollamudi; Glenn Heller; William Gerald; S Yeh; Ronald Finn; Steven M Larson; David Wuest; M Byrnes; E Dantis; Jaume Mora; Irene Y Cheung; NS Rosenfield; Sara Abramson; Richard J O'Reilly
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
Medical and pediatric oncology 2001;36(1):227-30.
2000: Jaume Mora; MUZAFFAR M AKRAM; Nai-Kong V Cheung; L Chen; William L Gerald
Laser-capture microdissected schwannian and neuroblastic cells in stage 4 neuroblastomas have the same genetic alterations.
Medical and pediatric oncology 2000;35(6):534-7.
2000: Jaume Mora; A M Dobrenis; J B Bussel; A Aledo
Spontaneous remission of congenital acute nonlymphoblastic leukemia with normal karyotype in twins.
Medical and pediatric oncology 2000;35(2):110-3.
2000: Jaume Mora; Daniel A Filippa; Howard T Thaler; Tatyana Polyak; Milicent Cranor; Norma Wollner
Large cell non-Hodgkin lymphoma of childhood: Analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial Sloan-Kettering Cancer Center.
Cancer 2000;88(1):186-97.
1999: Jaume Mora; Norma Wollner
Primary epidural non-Hodgkin lymphoma: spinal cord compression syndrome as the initial form of presentation in childhood non-Hodgkin lymphoma.
Medical and pediatric oncology 1999;32(2):102-5.
1998: Jaume Mora; M White; Ira J Dunkel
Listeriosis in pediatric oncology patients.
Cancer 1998;83(4):817-20.